Monday, November 15, 2021 Daily Archives

Ins and outs: AGC to address CGT needs through CBO hire

by

BioProcess Insider sat down figuratively with Jean-Baptiste Agnus, AGC Biologics’ chief business officer set to drive the contract development manufacturing organization (CDMOs) cell and gene therapy (CGT) business. Agnus joins AGC Biologics as chief business officer after three years with Ajinomoto Bio-Pharma Services where he was responsible for leading the firm’s global sales and marketing activities. Prior to this, he spent 13 years at Novasep, where he most recently held position of head of sales and business development North America.…

November 15, 2021

List forks out $125m+ for microbiome Indiana plant

by

List Therapeutics will increase manufacturing capacity for live biotherapeutics products (LBPs) with its $125+ million investment in Indiana, US. List Therapeutics, whose parent company is South Korean firm Genome & Company, will invest in the city of Fishers, Indiana to build a 110,000 square-foot  outsourcing  facility. According to the firm, the facility will be commissioned by the end of 2023 and will be located at the Fishers Life Science and Innovation Park. The plant expands List’s offering of end-to-end manufacturing…

November 15, 2021

Thermo Fisher and 3M team on chromatography tech

by

Leveraging Thermo Fisher’s single-use bioreactors systems with 3M’s purification platform aims to improve harvesting and clarification of monoclonal antibodies, the firms say. The collaboration – financials of which have not been divulged – allows Thermo Fisher to serve as an authorized reseller of 3M’s single-stage purification technology Harvest RC Chromatographic Clarifier with its own HyPerforma single-use bioreactor systems up to the 5,000 L scale. 3M’s tech is used to separate recombinant proteins, in particular monoclonal antibodies (mAbs) and according to…

November 15, 2021

Masco Group bolsters engineering tech with KeyPlants buy

by

Masco Group strengthens its engineering technologies for the life sciences sector by acquiring a majority stake in KeyPlants AB. The deal, of which no financial details have been disclosed, sees technological solutions provider Masco Group acquire Swedish firm Keyplants, which focuses on modular off-site construction for the life science industry. “This partnership will strengthen Masco Group by combining its leadership in clean utilities and process technologies with KeyPlants’ expertise and innovative energy in prefabricated, modular facility solutions,†a spokesperson for…

November 15, 2021